{"id":368024,"date":"2020-10-16T13:05:48","date_gmt":"2020-10-16T17:05:48","guid":{"rendered":"https:\/\/patientworthy.wpengine.com\/?p=368024&#038;preview=true&#038;preview_id=368024"},"modified":"2020-10-21T10:00:10","modified_gmt":"2020-10-21T14:00:10","slug":"un-nouveau-traitement-de-la-covid-19-passe-a-un-essai-de-phase-3","status":"publish","type":"post","link":"https:\/\/patientworthy.com\/fr\/2020\/10\/16\/un-nouveau-traitement-de-la-covid-19-passe-a-un-essai-de-phase-3\/","title":{"rendered":"Un Nouveau traitement de la COVID-19 passe \u00e0 un essai de phase 3"},"content":{"rendered":"<p><span lang=\"FR\">Grifols, une soci\u00e9t\u00e9 pharmaceutique bas\u00e9e \u00e0 Barcelone, en Espagne, a annonc\u00e9 que son traitement potentiel contre le nouveau coronavirus a pass\u00e9 \u00e0 un essai de phase 3, <a href=\"https:\/\/www.biospace.com\/article\/releases\/grifols-anti-sars-cov-2-hyperimmune-globulin-begins-clinical-trial-in-patients-with-covid-19\/?s=86\">selon <em>BioSpace<\/em><\/a>. Il est men\u00e9 en collaboration avec plusieurs agences f\u00e9d\u00e9rales am\u00e9ricaines, telles que le NIH. L&rsquo;intention de l&rsquo;essai est d&rsquo;\u00e9valuer l&rsquo;innocuit\u00e9, la tol\u00e9rance et l&rsquo;efficacit\u00e9.<\/span><\/p>\n<h2><span lang=\"FR\">\u00c0 propos de l\u2019essai<\/span><\/h2>\n<p>Cet essai \u00e9valuera la globuline hyperimmune anti-SARS-CoV-2 de Grifols, qui donne une concentration constante et \u00e9lev\u00e9e d&rsquo;anticorps neutralisants. Les cr\u00e9ateurs du m\u00e9dicament pensent qu&rsquo;il pourrait aider \u00e0 pr\u00e9venir et \u00e0 traiter la COVID-19. Ils croient que s&rsquo;il est administr\u00e9 lorsque les sympt\u00f4mes sont remarqu\u00e9s pour la premi\u00e8re fois, cela pourrait modifier la r\u00e9ponse immunitaire naturelle du corps et r\u00e9duire le risque de cas grave et de d\u00e9c\u00e8s.<\/p>\n<p>L&rsquo;essai lui-m\u00eame est multicentrique, international, randomis\u00e9, contr\u00f4l\u00e9 contre placebo, en double aveugle et adaptatif. 500 adultes hospitalis\u00e9s dans 18 pays recevront soit la globuline hyperimmunis\u00e9e anti-SRAS-CoV-2 en association avec le remdesivir, soit un placebo avec le remdesivir.<\/p>\n<p>Si cet essai r\u00e9ussi finalement, Grifols a d\u00e9clar\u00e9 qu&rsquo;il \u00e9tait pr\u00eat \u00e0 produire de gros volumes de traitement dans un courte dur\u00e9e. Ils travaillent \u00e9galement sur 25 autres initiatives pour lutter contre la COVID-19, dont beaucoup utilisent des traitements existants pour traiter le virus. Ils esp\u00e8rent que non seulement leur \u00e9tude de phase 3 sur la globuline hyperimmunis\u00e9e anti-SRAS-CoV-2 r\u00e9ussira, mais que leurs autres essais finiront de fa\u00e7on similaire.<\/p>\n<div class=\"elementor-element elementor-element-ace3425 elementor-widget elementor-widget-theme-post-content\" data-id=\"ace3425\" data-element_type=\"widget\" data-widget_type=\"theme-post-content.default\">\n<hr \/>\n<h4 class=\"footer-text\" style=\"text-align: center;\">What are your thoughts on being a rare disease advocate?\u00a0<a href=\"https:\/\/patientworthy.com\/register-2\/\">Share your stories, thoughts, and hopes with the Patient Worthy community!<\/a><\/h4>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Grifols, une soci\u00e9t\u00e9 pharmaceutique bas\u00e9e \u00e0 Barcelone, en Espagne, a annonc\u00e9 que son traitement potentiel contre le nouveau coronavirus a pass\u00e9 \u00e0 un essai de phase 3, selon BioSpace. Il est men\u00e9 en collaboration avec plusieurs agences f\u00e9d\u00e9rales am\u00e9ricaines, telles que le NIH. L&rsquo;intention de l&rsquo;essai est d&rsquo;\u00e9valuer l&rsquo;innocuit\u00e9, la tol\u00e9rance et l&rsquo;efficacit\u00e9. \u00c0 propos [&hellip;]<\/p>\n","protected":false},"author":1025,"featured_media":205473,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"ocean_front_end_style_editor":"no","ocean_post_layout":"","ocean_both_sidebars_style":"","ocean_both_sidebars_content_width":0,"ocean_both_sidebars_sidebars_width":0,"ocean_sidebar":"0","ocean_second_sidebar":"0","ocean_disable_margins":"enable","ocean_add_body_class":"","ocean_shortcode_before_top_bar":"","ocean_shortcode_after_top_bar":"","ocean_shortcode_before_header":"","ocean_shortcode_after_header":"","ocean_has_shortcode":"","ocean_shortcode_after_title":"","ocean_shortcode_before_footer_widgets":"","ocean_shortcode_after_footer_widgets":"","ocean_shortcode_before_footer_bottom":"","ocean_shortcode_after_footer_bottom":"","ocean_display_top_bar":"default","ocean_display_header":"default","ocean_header_style":"","ocean_center_header_left_menu":"0","ocean_custom_header_template":"0","ocean_custom_logo":0,"ocean_custom_retina_logo":0,"ocean_custom_logo_max_width":0,"ocean_custom_logo_tablet_max_width":0,"ocean_custom_logo_mobile_max_width":0,"ocean_custom_logo_max_height":0,"ocean_custom_logo_tablet_max_height":0,"ocean_custom_logo_mobile_max_height":0,"ocean_header_custom_menu":"0","ocean_menu_typo_font_family":"0","ocean_menu_typo_font_subset":"","ocean_menu_typo_font_size":0,"ocean_menu_typo_font_size_tablet":0,"ocean_menu_typo_font_size_mobile":0,"ocean_menu_typo_font_size_unit":"px","ocean_menu_typo_font_weight":"","ocean_menu_typo_font_weight_tablet":"","ocean_menu_typo_font_weight_mobile":"","ocean_menu_typo_transform":"","ocean_menu_typo_transform_tablet":"","ocean_menu_typo_transform_mobile":"","ocean_menu_typo_line_height":0,"ocean_menu_typo_line_height_tablet":0,"ocean_menu_typo_line_height_mobile":0,"ocean_menu_typo_line_height_unit":"","ocean_menu_typo_spacing":0,"ocean_menu_typo_spacing_tablet":0,"ocean_menu_typo_spacing_mobile":0,"ocean_menu_typo_spacing_unit":"","ocean_menu_link_color":"","ocean_menu_link_color_hover":"","ocean_menu_link_color_active":"","ocean_menu_link_background":"","ocean_menu_link_hover_background":"","ocean_menu_link_active_background":"","ocean_menu_social_links_bg":"","ocean_menu_social_hover_links_bg":"","ocean_menu_social_links_color":"","ocean_menu_social_hover_links_color":"","ocean_disable_title":"default","ocean_disable_heading":"default","ocean_post_title":"","ocean_post_subheading":"","ocean_post_title_style":"","ocean_post_title_background_color":"","ocean_post_title_background":0,"ocean_post_title_bg_image_position":"","ocean_post_title_bg_image_attachment":"","ocean_post_title_bg_image_repeat":"","ocean_post_title_bg_image_size":"","ocean_post_title_height":0,"ocean_post_title_bg_overlay":0.5,"ocean_post_title_bg_overlay_color":"","ocean_disable_breadcrumbs":"default","ocean_breadcrumbs_color":"","ocean_breadcrumbs_separator_color":"","ocean_breadcrumbs_links_color":"","ocean_breadcrumbs_links_hover_color":"","ocean_display_footer_widgets":"default","ocean_display_footer_bottom":"default","ocean_custom_footer_template":"0","ocean_post_oembed":"","ocean_post_self_hosted_media":"","ocean_post_video_embed":"","ocean_link_format":"","ocean_link_format_target":"self","ocean_quote_format":"","ocean_quote_format_link":"post","ocean_gallery_link_images":"off","ocean_gallery_id":[]},"categories":[13986],"tags":[14042],"_links":{"self":[{"href":"https:\/\/patientworthy.com\/fr\/wp-json\/wp\/v2\/posts\/368024"}],"collection":[{"href":"https:\/\/patientworthy.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/patientworthy.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/patientworthy.com\/fr\/wp-json\/wp\/v2\/users\/1025"}],"replies":[{"embeddable":true,"href":"https:\/\/patientworthy.com\/fr\/wp-json\/wp\/v2\/comments?post=368024"}],"version-history":[{"count":0,"href":"https:\/\/patientworthy.com\/fr\/wp-json\/wp\/v2\/posts\/368024\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/patientworthy.com\/fr\/wp-json\/wp\/v2\/media\/205473"}],"wp:attachment":[{"href":"https:\/\/patientworthy.com\/fr\/wp-json\/wp\/v2\/media?parent=368024"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patientworthy.com\/fr\/wp-json\/wp\/v2\/categories?post=368024"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patientworthy.com\/fr\/wp-json\/wp\/v2\/tags?post=368024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}